Skip to main content
MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.717
-0.009 (-1.23%)
At close: Oct 4, 2024, 4:00 PM
0.751
+0.034 (4.69%)
After-hours: Oct 4, 2024, 4:17 PM EDT

MiNK Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
31
Market Cap
28.35M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019689.63K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Concord Medical Services Holdings 64.91M
IRIDEX 49.70M
Equillium 42.62M
ImmuCell 23.22M
NeuroOne Medical Technologies 3.92M
IceCure Medical 3.34M
Dyadic International 1.80M
IGC Pharma 1.06M
Revenue Rankings

INKT News

More News